Associate Director, Early Development QA — Hybrid/Remote

Alnylam Switzerland GmbH

United States

Hybrid

USD 164,500 - 222,500

Full time

14 days+
Application generator

Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.

Get past ATS filters

Benefits offered by this job

Comprehensive medical, dental, and vision coverage
401(k) with generous company match
Paid time off and wellness days

Job summary

Alnylam Switzerland GmbH is seeking an Early Development Quality Lead responsible for strategic quality oversight of nonclinical studies and collaboration on quality-related activities within Alnylam. The role can be hybrid, onsite, or remote within the U.S.

The ideal candidate will have extensive experience in bioanalytical and toxicology, familiarizing with GLP, GCP regulations, and modern biomarker assays. Suitable applicants will also be part of a supportive work environment that offers competitive compensation and extensive benefits.

Qualifications

  • 8+ years of experience in bioanalytical and toxicology subjects.
  • Experience with GLP and GCP regulations.
  • Familiarity with modern biomarker-based assay techniques.

Responsibilities

  • Provide strategic quality oversight for nonclinical studies.
  • Collaborate with teams to ensure quality in lab management.
  • Implement robust vendor oversight and audit programs.

Skills

Bioanalytical expertise
Toxicology knowledge
Quality assurance
Assay development
Risk-based thinking

Education

Master’s degree in life sciences or related discipline

Tools

PCR
ELISA
FISH

Job description

Alnylam Switzerland GmbH is seeking an Early Development Quality Lead responsible for strategic quality oversight of nonclinical studies and collaboration on quality-related activities within Alnylam. The role can be hybrid, onsite, or remote within the U.S.

The ideal candidate will have extensive experience in bioanalytical and toxicology, familiarizing with GLP, GCP regulations, and modern biomarker assays. Suitable applicants will also be part of a supportive work environment that offers competitive compensation and extensive benefits.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Associate Director, Early Development Quality Lead, R&D QA
Associate Director, Early Development Quality Lead, R&D QA

Alnylam Switzerland GmbH • United States

Hybrid
USD 164,000 - 223,000
Comprehensive medical, dental, and vision coverage
401(k) with generous company match
Paid time off and wellness days
Vice President, Toxicology & Nonclinical Safety
Vice President, Toxicology & Nonclinical Safety

Alnylam Pharmaceuticals • Cambridge (MA)

On-site
USD 285,000 - 385,000
Senior QA Lead — Early-Stage Trials (GCP/GLP),Hybrid/Remote
Senior QA Lead — Early-Stage Trials (GCP/GLP),Hybrid/Remote

Scorpion Therapeutics • Boston (MA)

Hybrid
USD 140,000 - 190,000
Associate Director, Site & Monitoring Health Global Leader
Associate Director, Site & Monitoring Health Global Leader

Alnylam Pharmaceuticals • Cambridge (MA)

On-site
USD 173,000 - 233,000
Medical insurance
Dental insurance
Vision insurance
+6
Global Site & Monitoring Health Lead
Global Site & Monitoring Health Lead

Alnylam Pharmaceuticals, Inc. • United States

On-site
USD 173,000 - 233,000
Medical, dental, vision benefits
Life and disability insurance
401(k) with company match
+1
Global Clinical Trials Lead (Hybrid)
Global Clinical Trials Lead (Hybrid)

Alnylam Pharmaceuticals • Cambridge (MA)

Hybrid
USD 145,000 - 196,000
Bonus eligibility
Equity incentive
Medical insurance
+6
Remote Associate Director, Analytical Development & QC
Remote Associate Director, Analytical Development & QC

Entrada Therapeutics • Boston (MA)

On-site
USD 172,000 - 202,000
Hybrid Associate Director, External Analytical Development
Hybrid Associate Director, External Analytical Development

Valid8 Financial, Inc. • Berkeley (CA)

Hybrid
USD 170,000 - 210,000
Bonus/Equity Eligible
Senior Director, Clinical Pathology — Hybrid Cambridge
Senior Director, Clinical Pathology — Hybrid Cambridge

Alnylam Pharmaceuticals • Cambridge (MA)

Hybrid
USD 236,000 - 319,000
Onsite/hybrid in Cambridge
Senior Nonclinical Writing Lead for Regulatory Submissions
Senior Nonclinical Writing Lead for Regulatory Submissions

Alnylam Pharmaceuticals, Inc. • United States

Hybrid
USD 124,000 - 167,000
Medical, dental, vision coverage
401(k) with company match
Paid time off and holidays